Zhou Zijian, Jain Preetesh, Lu Yang, Macapinlac Homer, Wang Michael L, Son Jong Bum, Pagel Mark D, Xu Guofan, Ma Jingfei
Department of Imaging Physics, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
Am J Nucl Med Mol Imaging. 2021 Aug 15;11(4):260-270. eCollection 2021.
F-FDG PET/CT can provide quantitative characterization with prognostic value for mantle cell lymphoma (MCL). However, detection of MCL is performed manually, which is labor intensive and not a part of the routine clinical practice. This study investigates a deep learning convolutional neural network (DLCNN) for computer-aided detection of MCL on F-FDG PET/CT. We retrospectively analyzed 142 baseline F-FDG PET/CT scans of biopsy-confirmed MCL acquired between May 2007 and October 2018. Of the 142 scans, 110 were from our institution and 32 were from outside institutions. An Xception-based U-Net was constructed to classify each pixel of the PET/CT images as MCL or not. The network was first trained and tested on the within-institution scans by applying five-fold cross-validation. Sensitivity and false positives (FPs) per patient were calculated for network evaluation. The network was then tested on the outside-institution scans, which were excluded from network training. For the 110 within-institution patients (85 male; median age, 58 [range: 39-84] years), the network achieved an overall median sensitivity of 88% (interquartile range [IQR]: 25%) with 15 (IQR: 12) FPs/patient. Sensitivity was dependent on lesion size and SUV but not on lesion location. For the 32 outside-institution patients (24 male; median age, 59 [range: 40-67] years), the network achieved a median sensitivity of 84% (IQR: 24%) with 14 (IQR: 10) FPs/patient. No significant performance difference was found between the within and outside institution scans. Therefore, DLCNN can potentially help with MCL detection on F-FDG PET/CT with high sensitivity and limited FPs.
氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(F-FDG PET/CT)可为套细胞淋巴瘤(MCL)提供具有预后价值的定量特征。然而,MCL的检测是手动进行的,这劳动强度大,且并非常规临床实践的一部分。本研究探讨了一种深度学习卷积神经网络(DLCNN)用于在F-FDG PET/CT上对MCL进行计算机辅助检测。我们回顾性分析了2007年5月至2018年10月期间获取的142例经活检证实的MCL患者的基线F-FDG PET/CT扫描。在这142次扫描中,110次来自我们机构,32次来自外部机构。构建了一个基于Xception的U-Net,将PET/CT图像的每个像素分类为是否为MCL。该网络首先通过应用五折交叉验证在机构内部扫描上进行训练和测试。计算敏感性和每位患者的假阳性(FP)数用于网络评估。然后该网络在排除于网络训练之外的外部机构扫描上进行测试。对于110例机构内部患者(85例男性;中位年龄58岁[范围:39 - 84岁]),该网络实现了总体中位敏感性为88%(四分位间距[IQR]:25%),每位患者有15个(IQR:12个)FP。敏感性取决于病变大小和标准化摄取值(SUV),但不取决于病变位置。对于32例外部机构患者(24例男性;中位年龄59岁[范围:40 - 67岁]),该网络实现了中位敏感性为84%(IQR:24%),每位患者有14个(IQR:10个)FP。在机构内部和外部扫描之间未发现显著的性能差异。因此,DLCNN可能有助于在F-FDG PET/CT上以高敏感性和有限的FP数检测MCL。